Abstract | Stem cells are endowed with the potential for self-renewal and multipotency. Pluripotent embryonic stem cells have an early role in the formation of the three germ layers (ectoderm, mesoderm and endoderm), whereas adult tissue stem cells and progenitor cells are critical mediators of organ homeostasis. The adrenal cortex is an exceptionally dynamic endocrine organ that is homeostatically maintained by paracrine and endocrine signals throughout postnatal life. In the past decade, much has been learned about the stem and progenitor cells of the adrenal cortex and the multiple roles that these cell populations have in normal development and homeostasis of the adrenal gland and in adrenal diseases. In this Review, we discuss the evidence for the presence of adrenocortical stem cells, as well as the various signalling molecules and transcriptional networks that are critical for the embryological establishment and postnatal maintenance of this vital population of cells. The implications of these pathways and cells in the pathophysiology of disease are also addressed.
Introduction
The adrenal cortex produces different cortico steroid hor mones necessary for human life. The organ is sub divided into discrete histological and functional steroido genic cell layers under the control of distinct endocrine signals. Despite the fairly concentric zonation of these layers under normal physiological conditions, dynamic centri petal 'streaming' of adrenocortical cells occurs throughout life. Adrenocortical cells proliferate under the capsule and are displaced centripetally until they undergo apoptosis at the adrenocortical-medullary boundary. Maintenance of adrenal volume and function presumably necessitates replenishment of steroidogenic cells from a pool of somatic stem and progenitor cells. Pluripotent embryonic stem cells have an early role in the formation of the three germ layers (ectoderm, mesoderm and endoderm), whereas somatic stem cells are responsible for post developmental and homeostatic tissue maintenance of most organs. 1 Such cells are described as longlived, slowcycling and clono genic cells, and simultaneously possess the abilities of self renewal and terminal differen tiation. Whereas stem cells retain the capacity to proliferate indefinitely, their daugh ter progenitor cells are more committed in lineage and are thought to possess limited replicative potential. 2 In this Review, we discuss the current knowledge on the establishment and maintenance of adrenocortical stem and progenitor cells. We first discuss basic adrenal bio logy and detail evidence for the presence of adreno cortical cells with stem or progenitorlike capacities. We then des cribe the process of adrenal development, postnatal tis sue main tenance and the various origins and descendants of adrenocortical cell lineages. We summarize how adrenal organogenesis and postnatal homeo stasis are regulated by a large array of signalling molecules, including combinato rial inputs from distinct paracrine signalling pathways and the endocrine system. Clinical consequences of stem cell failure and un mitigated activation of associated paracrine signalling pathways are also discussed.
Adrenal anatomy and function
The adrenal gland is composed of two discrete endocrine organs with distinct embryological origins. The inner adrenal medulla, formed from the neural crest, produces catecholamines that are mediators of the 'fightorflight' response. The outer adrenal cortex, derived from the inter mediate mesoderm, is the primary site of corticosteroid biosynthesis. The organization of the adrenal cortex was first described in 1866 by Julius Arnold, whose nomen clature remains in use today. 3 The adrenal cortex is sub divided into three separate histological and functional zones, each responsible for the production of steroid hor mones that mediate different aspects of stress response and homeostasis. The outermost layer, the zona glomerulosa, is composed of cellular rosettes that secrete the mineralo corticoid aldosterone, which contributes to maintenance of electrolyte balance, under the control of serum potas sium levels and the renin-angiotensin-aldosterone system (RAAS). When stimulated by the hypothalamic-pituitaryadrenal (HPA) axis, the middle zona fasciculata produces glucocorticoids (cortisol in humans and cortico sterone in mice) to facilitate the mobilization of energy stores in response to stress (real or perceived threats to body integ rity). The innermost zona reticularis contains a network of cells that synthesize androstenedione and dehydroepi androsterone that are precursors to sex steroid hormones. The developmental establishment of the adrenal cortex
Evidence for adrenocortical stem cells
Many studies have provided evidence for the existence of adrenocortical cells with stemlike and progenitor like capacities. Undifferentiated adrenocortical cells with limited steroidogenic capacity have been described across mammalian species. In mice and humans, the outermost layer of the adrenal cortex, the zona glomerulosa, contains differentiated aldosteroneproducing cells intermingled with clusters of undifferentiated cells. 5, 6 In rats, an undif ferentiated zone exists between the zona glomerulosa and the zona fasciculata, and is referred to as the zona inter media. 7 In the adrenal glands of the common seal (Phoca vitulina vitulina), groupings of large rounded cells that have been described as 'adrenocortical blastema' (undif ferentiated cells capable of adrenocortical regeneration) are found adjacent to trabeculae of connective tissue extending from the capsule. 8 These cell clusters are likely to represent homologous groups of adrenocortical stem and progenitor cells in the different species.
The continued proliferative capacity of the adult adrenal gland to maintain adrenal volume and function through out life is consistent with the presence of a stemlike population of cells. In experiments performed as early as the 1930s, complete restoration of adrenocortical mass was observed within 6 weeks after adrenal enuclea tion (removal of most of the cortex and medulla that leaves behind just the capsule and the underlying outermost cortical layer), 9 which is consistent with clonal expansion and differentiation of a peripheral stem and progenitor cell population. More recent studies demonstrated that when primary cultures of bovine adrenocortical cells were transplanted underneath the kidney capsules of adrenalec tomized immunocompromised mice, func tional vascularized s teroidsecreting adrenocortical tis sue was reconstituted. 10, 11 Under normal homeostatic conditions, cells proliferate in the outermost layers of the adrenal cortex and capsule. Tritiated thymidine and bromo deoxyuridine (BrdU) pulse-chase experiments in rodents have established that cells labelled in the periph ery of the adrenal cortex are centripetally displaced until they reach the cortical-medullary boundary where they undergo apoptosis. [12] [13] [14] [15] Observations of chimaeric trans genic mice expressing a reporter gene in a radial pattern 19 Genetic experiments within the past decade have defined the clonal relationship between inner adreno cortical cells and overlying capsular and s ubcapsular cells (see discussion below and Figure 1 ).
Adrenal development and homeostasis
Overview of adrenal organogenesis Cells destined to become adrenocortical cells originate from the coelomic epithelium and condense to form a shared embryological structure, the adrenogonadal pri mordium (AGP), that is the precursor of the steroido genic organs, the gonads and the adrenal glands. The AGP appears around 3-4 weeks postconception in humans and embryonic day (E) 9.0 in mice. [20] [21] [22] Establishment of the AGP is followed by its separation into adrenal and gonadal primordia, with subsequent mesenchymal cell encapsula tion of the adrenal primordium (the 'fetal adrenal gland') by 9 weeks postconception in humans or E12.5 in mice. Concomitant with encapsulation of the fetal adrenal gland, sympathoadrenal precursors destined to become the adrenal medulla begin migrating into the fetal adrenal gland from the neural crest. 4, 23 Following encapsulation, the developing adrenal gland grows owing to the emer gence of definitive or 'adult' adrenocortical cells between the fetal gland and the capsule while the fetal adrenocorti cal cells begin to regress (Figure 1 ). At the time of birth, the majority of the adrenal cortex is comprised of defini tive adrenocortical cells, whereas only a small ring of the fetal adrenocortical cells remains. 4 This remaining layer of fetal adrenocortical cells regresses shortly after birth in humans, but does not disappear until puberty in male mice and during the first pregnancy in female mice.
Postnatal growth and homeostasis
Definitive adrenocortical cells emerge during late embryo genesis and zonation of the adrenal cortex into distinct steroido genic layers is completed in the perinatal period with the onset of specific expression of Cyp11b2 in the zona glomerulosa. 24 In humans and some non human primates, the zona reticularis emerges at the onset of adrenarche, an early step in sexual maturation that is ini tiated by androgen secretion from the adrenal cortex. 25 Homeostasis of the postnatal adrenal gland is maintained by the balance between cell proliferation at the outer cortex, centripetal migration of differentiating cells, and apoptosis of cells at the cortical-medullary boundary ( Figure 2 ). As discussed above, some of the first studies of adrenal gland biology in the early 1930s observed that adult adrenal glands contain a subset of peripheral cells with continual proliferative potential and the capacity to regenerate adrenocortical tissue. Data published in 2013 confirmed and expanded these earlier observa tions by showing that newly formed, proliferating cells (as seen with BrdU labelling) in the outer adult adrenal cortex do not colocalize with steroidogenic markers, but become differentiated as they are centripetally displaced. 15 Additionally, a small fraction of label retaining cells remains in the capsule and subcapsular cortex 23 weeks after a BrdU pulse. 15 This finding is consistent with the presence of a slowly cycling or fairly quiescent stem cell population. These data further support the idea that homeostatic adrenocortical growth is maintained by a persistent population of undifferentiated cells existing in both the capsule and the outer adrenal cortex.
Adrenocortical stem cell lineages
The search for adrenocortical stem and progenitor cells has revealed very complex cell lineage relationships in which the adrenal capsule provides precursors of adult adreno cortical cells and that at least some capsular cells are derived from fetal adrenal cells of the adrenal pr imordium (Figure 1 ).
Fetal adrenal cells give rise to adult cells AGP formation and subsequent adrenal gland develop ment is critically dependent on the expression of Nr5a1, which encodes the nuclear receptor steroidogenic factor 1 (SF1, also known as adrenal 4binding protein or steroid hormone receptor Ad4BP). (Table 1) . 21 In addition to its presence in the adrenal glands and gonads, SF1 expression is found in nonsteroidogenic tissues such as the ventromedial hypothalamus, 30 pituitary gonado tropes 31 and the spleen. 32 Distinct tissuespecific en hancers of the Nr5a1 gene mediate expression of SF1 in these organs. Analysis of the transcriptional regula tion of Nr5a1 identified a fetal adrenal enhancer (FAdE), whose activity is solely restricted to fetal adrenal cells. Activation of FAdE is initiated by complexes of transcrip tion factors (the homeobox proteins PBX1, PKNOX1 and HOX) and later maintained in an autoregulatory manner by SF1. 33 Lineagetracing experiments utilizing FAdE driven Cre recombinase (FAdE-Ad4bp-Cre) revealed that FAdEdrivenAd4bpexpressing cells were precur sors of most, if not all, SF1positive (SF1 + ) cells in the adult adrenal cortex. 34 Interestingly, experiments using a FAdE-CreERT2 inducible allele demonstrated that only FAdEdrivenAd4bpexpressing cells that were marked prior to fetal adrenal encapsulation could be precursors of adult adrenal cells. When induction takes place on or after E14.5, FAdEderived adult adrenocortical cells were no longer detected. 34 These data suggest that an initial popu lation of fetal adrenal cells contributes to the lineage of adult adreno cortical cells, a process that occurs ex clusively during early embryonic life. 39 three independent laboratories studying the Hedge hog pathway in the adrenal gland also provided gen etic evi dence for this phenomenon. A family of secreted Hedge hog molecules, consisting of sonic he dgehog (SHH), desert hedgehog (DHH) and indian hedgehog (IHH), exists in mammals. These ligands bind to the cell surface recep tor protein patched homolog 1 (PTC1). In the absence of Hedgehog ligands, PTC1 inhibits the positive signal transducer smoothened homolog (SMO), allowing pro teolytic processing of GLI transcription factors, which generates transcriptional corepressor forms of these pro teins. Hedgehog binding to PTC1 relieves inhibition of SMO, which results in activation of downstream signal ling that inhibits proteo lysis of GLI proteins. Hedgehog target genes, including Gli1 and Ptch1 (which encodes PTC1), are induced by active GLI transcription factors and are important for feedback regu lation of this signal ling pathway. 35 In the adrenal gland, SHH is expressed in peripheral SF1
+ adreno cortical cells from E12.5 onward ( Figure 3) . [36] [37] [38] These cells rarely co localize with steroido genic markers during development or postnatal life and remain fairly undifferentiated. 36 The SHH protein secreted by SF1 + cells acts upon SF1 -cells that reside within an inner layer of the adrenal capsule; these cells express Smo, Ptch1 and Gli1. [36] [37] [38] Cell lineage analysis with mice express ing the ROSA26-YFP reporter construct crossed with mice harbouring a Cre recombinase replacing the endogenous Shh locus (Shh gfpcre :R26-YFP) revealed that, postnatally, all cells of the cortex (but not of the capsule or medulla) were derived from Shhexpressing fetal cells. 36 Further experiments utilizing mice with an inducible ShhCre allele crossed with mice expressing the ROSA26-mT/mG reporter (Shh-CreT2:R26-mR/mG mice) showed that shortly after labelling, Shhexpressing cells remain restricted to the peripheral cortex. 36 Over time, these cells and their descendants form clonal, radial stripes that extend deep into the cor tex and colocalize with steroidogenic cells of both the zona glomerulosa and the zona fasciculata. 41 These data indicate that the adrenal capsule contains several populations of multipotent adreno cortical stem and progenitor cells that have the capacity to differentiate into adrenallike or gonadal like cells in response to activation of the HPA versus the h ypothalamic-pituitary-gonadal axes.
Fetal adrenal cells become capsular stem cells Data discussed above indicate that both fetal adrenal cells expressing Nr5a1 under the control of the FAdE enhancer and SF1
-capsular cells are precursors of defini tive adreno cortical cells. A unifying model integrating these observa tions would predict that a subpopulation of fetal adrenal cells could contribute to the forming capsule and switch off Nr5a1 expression. 42 These cells or their descendants would express Gli1 in the capsule and give rise to adult adreno cortical cells expressing Nr5a1 under the control of the 39 These data collectively demonstrate that SF1 expression is extinguished in the capsular descendants of fetal adrenal cells, which contribute to the popu lation of SF1 -;Gli1 + cap sular cells (Figure 1 ). The data unify the seemingly con flicting reports on the cell lineage re lationships of adult adrenocortical precursors.
Zonation and lineage conversion
Definitive adrenocortical cells arise during embryo genesis, but zonation of the adrenal cortex into distinct steroidogenic layers occurs perinatally. The pattern of zonation is fairly constant under normal physiological conditions but the process of centripetal displacement sug gests that each cell transits through various compartments of the adrenal cortex throughout its limited lifespan. In 1883, Max Gottschau proposed the centri petal migration model in which progenitor cells in the peripheral cortex of the adrenal gland first differentiate into mineralocorticoid producing cells in the zona glomerulosa and upon centri petal migration transform into glucocorticoidproducing cells of the zona fasciculata. 43 On the basis of the disparate effects of hypophysectomy on the zona glomerulosa and zona fasciculata (broadening of the zona glomerulosa with atrophy of the zona fasciculata), along with the dis tinct functions of the steroids produced from these zones (previously discussed), a separate model hypothesized that each steroidogenic layer contains its own progenitor pool. 44 Although tritiated thymidine, BrdU and trypan blue pulse-chase experiments support the centripetal migration model, none of these studies directly tested lineage conver sion of a zona glomerulosa cell to a zona fasciculata cell. Genetic evidence for this conversion was provided in 2013 by celllineagetracing experiments in mice harbouring a Cre recombinase gene inserted at the Cyp11b2 locus, in which Cre was expressed only in terminally differentiated zona glomerulosa cells (AS Cre mice). 45 When these mice were crossed with mice expressing the R26R mT/mG reporter, GFP + cells appeared in the zona glomerulosa from the outset of Cyp11b2 expression and eventually populated the entire zona glomerulosa. 45 Of note, Cyp11b1expressing cells in the zona fasciculata (which do not express Cyp11b2) also became GFP + over time, indicating that these cells underwent lineage conversion from zona glomerulosa cells. In 12weekold mice, nearly the entire cortex was GFP + . 45 This phenomenon was also observed under forced homeo static maintenance of the cortex, during the pro cess of regeneration following dexamethasoneinduced atrophy of the zona fasciculata; 8 weeks following with drawal of dexamethasone, AS +/Cre :R26R +/mTmG mice exhib ited GFP + cells in the zona fasciculata, 45 indicating lineage conversion of zona glomerulosa cells to zona fasciculata cells still occurred under this homeostatic paradigm.
Regulation of adrenocortical stem cells

Transcription factors
SF-1
As mentioned above, SF1 is an essential regulator of adrenal development and steroidogenic function. Two laboratories independently identified SF1/Ad4BP as the nuclear receptor that activates transcription of the steroido genic enzymes responsible for catalyzing steroid bio synthesis. 46, 47 Shortly thereafter, the importance of SF1 in specification of adrenal cell identity and in adrenal growth became evident from studies of mice in which the Nr5a1 gene was knocked out. SF1 expression starts at E9.0 in the urogenital ridge, where it specifies precur sors of the steroido genic lineage and leads to the forma tion of the AGP. 48 Mice globally deficient for SF1 exhibit degenera tion of the AGP due to apoptosis between E11.5 and E12.0, which results in agenesis of the adrenal glands and gonads. 21 Unlike Nr5a1 knockout animals, mice hetero zygous for Nr5a1 survive to adulthood yet possess smaller adrenal glands that have reduced capacity for cortico sterone production under conditions of stress. 49 Of note, Nr5a1 hetero zygotes are unable to mount a compen satory growth response following unilateral adrenalectomy owing to lack of peripheral adrenal cell proliferation. 50 Although the incidence of NR5A1 mutations in humans is low, patients with mutations in the DNAbinding domain of SF1 exhibit primary adrenal failure and gonadal d ysgenesis (Table 1) . 51, 52 In a genetic mouse model in which SF1 overexpression is mediated by the FAdE enhancer (FAdE-Ad4BP[Ad4BP/ SF-1] transgenic mice), the animals exhibit ectopic for mation of adrenal tissue throughout the thoracic cavity. 53 Similarly, forced expression of SF1 in embryonic 54 and mesenchymal stem cells 55 is sufficient to promote steroido genic cell differentiation in vitro. Other studies have dem onstrated that increased subcapsular proliferation occurs in mice with transgenic overexpression of SF1. 56 Ampli fication and overexpression of SF1 are associated with paediatric adrenocortical adenomas and carcinomas, [57] [58] [59] and are correlated with poor clinical outcomes in patients with adrenocortical carcinomas (Table 1) . 60 Altogether, these data highlight a critical role for SF1 in the regulation of adrenocortical cell specification, dif ferentiation and proliferation. How does SF1 mediate the seemingly opposing tasks of proliferation and differentia tion? Regulation of the transcriptional activity of SF1 by posttranslational modifications and/or stimulatory and inhibitory ligands has been posited to dictate what genetic programs are enacted by SF1; this topic has been reviewed elsewhere. 61, 62 The role of these modifications on the tran scriptional activity of SF1 and its effects on homeostatic maintenance is an area of active investigation.
DAX-1
The Nr0b1 gene encodes DAX1 (nuclear receptor sub family 0 group B member 1), an atypical nuclear recep tor that lacks a classic nuclear receptor DNAbinding domain, instead containing threeandahalf repeated aminoacid stretches rich in glycine and alanine. 63 Initial reports showed that DAX1 functions as a negative regu lator of SF1mediated transcription 64 and these findings were subsequently extended to other nuclear receptors. 65 Whereas DAX1 recruits the corepressors NCoR and ALIEN for transcriptional inhibition, 66 ,67 data suggest DAX1 also has a dosedependent coactivator capacity.
68
DAX1 inhibits SF1mediated steroidogenesis in vitro and in vivo. 69 Additionally, DAX1 directly represses Star, which encodes steroidogenic acute regulatory protein, by binding to hairpin structures present in the promoter region of this gene. 70 Whether DAX1 exerts its inhibitory actions on steroidogenesis in differentiated cells or in pro genitor cells in which steroidogenesis is uniquely down regulated was unclear. More recent studies have shown that DAX1 is essential to maintain embryonic stem cell pluripotency. [71] [72] [73] [74] Data from our laboratory show that in the adult murine adrenal cortex, DAX1 is critical for mainte nance of adreno cortical progenitor cells. When compared with wildtype littermates, DAX1 knockout mice exhibit enhanced steroidogenesis and proliferation at early ages but display progressive loss of proliferating cells, which is associated with adrenal gland dysplasia and hypofunction, as they age. 75 Mutations or deletion of NR0B1 in humans are the under lying basis of Xlinked adrenal hypoplasia con genita (AHC; Table 1) . 63, 76 Classically, these patients pre sent with pri mary adrenal insufficiency and hypo gonado tro pic hypo gonadism, although a subset of patients exhi bit signs of adrenal hyperfunction prior to adrenal failure. 77, 78 These human data together with the DAX1 knockout mouse study indicate that DAX1 deficiency leads to pre cocious differentiation of adrenocortical progenitor cells, which ultimately leads to progenitor depletion and adrenal insufficiency.
Paracrine signalling pathways
Wnt signalling
The mammalian winglesstype MMTV integration site (Wnt) pathway is a paracrine signalling pathway critically involved in development and stemcell maintenance in multiple organ systems. 79 Secreted Wnt molecules bind to a variety of receptors (including the frizzled family, and the receptor tyrosine kinases RYK and ROR) to elicit distinct downstream signalling through the canonical Wnt-β catenin pathway and/or the noncanonical Wnt (planar cell polarity) and calcium signalling pathways. 80 For activa tion of the canonical pathway, Wnt ligands bind to frizzled receptors resulting in the inactivation of the multiprotein complex that promotes the destruction of the transcrip tion factor βcatenin. Once freed from the destruction complex, βcatenin enters the nucleus and transactivates Wntresponsive genes through interaction with DNA bound TCF/LEF transcriptional regulators. In the devel oping adrenal glands of mice, βcatenin expression occurs as early as E12.5. 81 In transgenic mice expressing reporter genes, active canonical Wnt-βcatenin signalling is evident in a few scattered cells in the periphery of the adrenal gland at this time. By E18.5, Wnt-βcatenin signalling is restricted to the outer subcapsular region of the adrenal cortex. 81 75, 82 Con versely, mice in which adrenocortical Wnt-βcatenin signalling is upregulated, either through genetic deletion of Apc (a factor critical for adequate function of the βcatenin destruction complex) or through gain of a constitutively active Ctnnb1 allele, display increased subcapsular prolif eration 83, 84 and exhibit progenitor cell expansion. 84 In addi tion, observations in mice suggest βcatenin facilitates the differentiation of zona glo merulosa cells while suppress ing differentiation of the zona fasciculata through indirect regu lation of aldosterone production, 83, 85 as well as through inhibition of Cyp11b1 expression and cortico sterone pro duction. 86 Alterations resulting in Wnt pathway activation, such as genetic loss of APC 87 or gainof function muta tions in CTNNB1, 88 are frequent perturbations in human adrenocortical carcinomas and are correlated with poor prognosis (Table 1) . 84, 88, 89 These collective data support a role for Wnt-βcatenin signalling in the maintenance and commitment of the adrenocortical progenitor pool.
The WNT4 ligand is expressed in the developing adrenal glands of mice as early as E11.5, with restricted expres sion in the periphery of the cortex observable by E14.5.
5
Whether Wnt4 expression is a cause or a consequence of the activated canonical Wnt pathway remains unclear, as Wnt4 is genetically downstream of βcatenin in other tissues. 90, 91 Mice globally deficient for Wnt4 have fairly normal adrenal gland size and morphology during devel opment, but exhibit reduced Cyp11b2 expression at birth resulting in decreased aldosterone production.
5 Wnt4 knockout mice also contain ectopic adrenocortical cells at the anterior tips of the gonads, the gonadal region that is closest to the forming adrenal glands. Given the shared lineage between the adrenal glands and the gonads, these data suggest that WNT4 regulates adrenal cell homing or specification during separation of the AGP in early adrenal development. 5, 92 In humans, WNT4 lossoffunction muta tions result in SERKAL syndrome, an autosomalrecessive disorder whose manifestations include female sex rever sal and dysgenesis of the kidneys, lungs and adrenal glands (Table 1) . 93 In contrast to mice, human fetuses with SERKAL syndrome have reduced adrenal gland size but fairly normal adrenal histology. 93 SHH signalling SHH signalling is implicated in developmental pattern ing and stem cell biology in many tissues in species from flies to humans. 35 Evidence for the importance of SHH sig nalling in adrenal gland development arose from the discovery that frameshift mutations that result in trunca tion of GLI3 into a constitutive repressor are the underlying cause of Pallister-Hall syndrome (PHS). 94 PHS is charac terized by a constellation of congenital anomalies including poly dactyly, hypothalamic hamartoma, kidney abnormali ties and adrenal insufficiency. 95 Studies of a genetic mouse model of PHS with a truncated GLI3 protein (GLI3Δ699) have led to discrepant findings; one research group reported these mice had adrenal aplasia, 96 whereas another group found no adrenal malformations in these animals. 97 Despite the findings of the second of these studies, several reports have highlighted a critical role for SHH in adreno cortical progenitor biology, as previously discussed. [36] [37] [38] ), exhibit hypo plastic adrenal glands during embryonic development, owing to reduced cortical and capsular cell proliferation (Table 1) . 37, 38 Adult Sf1/Cre:Shh fl/-adrenal glands contain fewer cells that are hypertrophic yet retain the capacity of steroid secretion. 38 Despite having smaller adrenal glands, Shhdeficient mice have adrenal histology and organiza tion comparable to those in their wildtype counterparts, indicating that adreno cortical encapsulation and zona tion, as well as migration of medullary cells, do not rely on SHH signalling. However, Sf1/Cre:Shh fl/-embryo nic and adult adrenal glands possess markedly thinner cap sules compared with wildtype glands. 36, 38 Coupled with the observation that Shhdeficient mice have reduced capsular proliferation, these data indicate SHH might be a regulator of mitogenic signalling for capsular stem and progenitor cells.
FGF signalling
The complexity of the fibroblast growth factor (FGF) sig nalling pathway is due to the diversity of ligands, recep tors and receptor isoforms, as well as to the diversity of the intracellular signalling cascades that participate in FGF signal transduction. Binding of FGFs to FGF recep tor (FGFR) tyrosine kinases is facilitated by transmem brane heparan sulfate proteoglycans. Ligand binding promotes FGFR dimerization and autophosphorylation, which can stimulate multiple downstream signalling pathways, including the JAK-STAT (Janus kinase and signal transducer and activator of transcription), phos pholipase C (PLC) γ, PI3K (phosphatidylinositol4,5 bisphosphate 3kinase) and MAPK (mitogenactivated protein kinase) pathways. 98 Both the adrenal capsule and the adrenal cortex express components of the FGF pathway (Figure 3 ). FGF2 and FGF9 expressed in the capsule signal to FGFR1 IIIc and FGFR2 IIIc, which are expressed in both the cortex and the capsule. 99 ,100 FGF1 secreted from the cortex is thought to elicit signalling from FGFR1 IIIc, FGFR2 IIIb and FGFR2 IIIc, which are expressed in both compartments. 99, 100 Ablation of Fgfr2 in steroidogenic cells results in adrenal hypoplasia observable by E15.5. 101 The effects of FGFR2 deletion are predicted to be solely due to loss of the IIIb isoform, as global deletion of Fgfr2 IIIb results in embryonic adrenal hypoplasia, 99, 102 whereas the adrenal glands of Fgfr2 IIIc knockout mice have no discernible phenotypic differences from wild type glands at postnatal day 2. 103 The adrenal hypoplasia evident in Fgfr2-IIIbdeficient mice results from reduced cortical proliferation during embryo genesis (Table 1) , 99 which demonstrates a requirement for mitogenic FGF signalling for proper adrenal gland development. FGFs also exert mitogenic effects important for adrenal gland maintenance in the postnatal period. FGF2 has been reported to stimulate proliferation in primary cultures of bovine adrenocortical cells and the Y1 mouse tumour cell line. 104, 105 Adrenal regrowth under the paradigm of reconstitution by injecting primary adrenocortical cells in mice or following unilateral adrenalectomy in mice is critically dependent on the proproliferative and angiogenic properties of FGFs. 11, 106, 107 In humans, over expression of FGFR1 and FGFR4 has been found in adrenocortical adenomas and adrenocortical carcinomas (Table 1) . [108] [109] [110] FGFR4 overexpression was detected in up to 65% of adreno cortical tumours and is a predictor of poor outcome, and, therefore, a new potential target for the treatment of ad renocortical carcinoma. 110 
TGF-β and inhibin signalling
The transforming growth factor β (TGFβ) signalling path way affects a wide variety of cellular processes and is involved in maintenance and differentiation of stem cells. 111 The TGFβ superfamily consists of a diverse array of ligands, including (but not limited to) bone morpho genetic proteins, growth and differentiation factors, activins and inhibins. Ligand binding to TGFβ receptor type2 (TGFR2) promotes phosphorylation of TGFβ recep tor type1 (TGFR1), which in turn results in phos phorylation and nuclear translocation of mothers against decapentaplegic (SMAD) proteins that modulate tran scription of target genes. Activins and inhibins are present in the fetal and adult adrenal cortex 112 and profoundly influence adrenocortical differentiation. Activins augment steroidogenesis induced by adrenocorticotropic hormone (ACTH) in fetal adrenal cells and stimulate aldosterone production induced by angiotensin II (Ang II) and ACTH in adult adrenal cells. 112, 113 Whether inhibins directly affect adrenal steroidogenesis is unclear; 114 however, an impor tant role for the gene encoding inhibinα (Inha) in the biology of adrenocortical progenitor cells has been dem onstrated. Following gonadectomy, Inhadeficient mice develop estrogensecreting steroido genic tissue in the adrenal cortex, 115 a process that is dependent on high levels of circulating luteinizing hormone (LH). 116 LH induces a transcriptional program switch from adrenalspecific Gata6 expression to gonadalrestricted Gata4 expres sion. 117 The loss of Inha results in constitutive TGFβ2 and SMAD3 activation in adrenocortical progenitor cells, with subsequent expansion of GATA4expressing cells. The resultant ectopic ovarian tissue includes differentiated theca and granulosa cell lineages and partially matured follicles. 117 These data establish a role for inhibinα in the determination of the adrenal (versus gonadal) fate of adrenocortical progenitor cells. Whether the ovarian theca meta plasia observed in the adrenal cortex of postmeno pausal women reflects c onstitutive TGFβ2 activation remains an in triguing hypothesis. 118 
IGF signalling
The insulinlike growth factor (IGF) signalling pathway has been implicated in growth and differentiation of the adrenal cortex. The IGF family consists of two ligands structurally similar to proinsulin, IGF1 and IGF2. These secreted proteins interact with IGF1 receptor (IGF1R), a receptor tyrosine kinase structurally similar to the insu lin recep tor, to promote cell growth and survival, signal ling through MAPK and/or PI3K-AKT (also known as protein kinase B) pathways.
119 IGF2 receptor (IGF2R), unlike IGF1R, does not contain a tyrosinekinase domain and acts as a molecular sink to restrict the bioavailability of IGF2. 119 Six IGFbinding proteins (IGFBPs) bind to and exert stimulatory or inhibitory effects on IGFs; how ever, their actions in the adrenal gland are poorly understood. All components of the IGF pathway are expressed in the adrenal gland across mammalian species. 4 IGFs have strong mitogenic effects on fetal and adult human 120 and bovine 121 adrenal cells. IGF2, the gene that encodes IGF2, is highly expressed in human fetal adrenal glands. How ever, IGF2 expression is decreased in the adult adrenal gland to a level equivalent to the expression level of IGF1. 119 IGFRs are expressed throughout all zones of the human adre nal cortex, with enrichment of IGF1R in the subcapsul ar region. 122 Mice deficient in both the insulin receptor gene (Insr) and Igf1r exhibit gonadal dysgenesis, maletofemale sex reversal and adrenal aplasia. 123 Adrenal agenesis is evident by E16.5 and is likely to be due to global loss of cell proliferation throughout the genital ridge and the AGP beginning as early as E10.5. 123 Mice with an Insr and Igf1r double knockout have an AGP containing almost half the number of SF1 + cells found in wildtype mice at E11.5, as well as having reduced Nr5a1 expression. These data indicate that IGF signalling is a potent adrenal mitogen and is critical for adrenal cell specification early in devel opment. Additionally, IGFs augment basal and ACTH induced steroido genesis in both fetal and adult adrenal cells in vitro, 124 suggesting a role for IGF signalling in adrenocortical cell differentiation in addition to adrenal cell proliferation.
IGF2 is located on chromosome 11p15.5 within an imprinted locus that also includes CDKN1C, which encodes the cyclindependent kinase inhibitor 1C (also known as p57Kip2), and H19, which is transcribed into a nontranslated RNA. 125 Genetic and epigenetic aberrations in this locus result in diseases with clini cally impor tant adrenal gland abnormalities, such as Beckwith-Wiedemann syndrome (BWS) and IMAGe (intrauterine growth retardation, metaphyseal dysplasia, AHC and genital anomalies) (Table 1) . BWS, a hetero geneous pa ediatric overgrowth syndrome characterized by embryo nic tumours, macrosomia, macroglossia and other developmental defects, results from loss of imprint ing of 11p15.5 leading to upregulation of IGF2 and down regulation of CKDN1C and H19. 125 Whereas the common adrenal pheno type in patients with BWS is adrenal cyto megaly with adrenocortical cysts, 126, 127 adrenocortical carcinoma occurs in 7% of BWS cases. 127 Of note, IGF2 was found to be markedly upregulated in most genomic studies of sporadic adrenocortical carcinoma, with loss of methylation marks observed at the IGF2 locus, 89, 128, 129 as reviewed previously. 130 Interestingly, loss of the major imprinting control region of the Igf2 locus in the mouse adrenal gland increases Igf2 expression but does not by itself increase the incidence of adrenal tumours. How ever, in combination with genetically increased βcatenin levels, elevated IGF2 expression contributes to an earlier for mation and increased severity of adrenocortical tumours in mice. 84, 131 In contrast to BWS, IMAGe is characterized by adrenal insufficiency. The constellation of congenital anomalies that characterize IMAGe result from gainof function mutations in CDKN1C that increase the stability of the p57Kip2 protein. 132, 133 Endocrine signalling pathways The peptide hormones Ang II and ACTH mediate differ ent aspects of endocrine homeostasis through regulation of adrenocortical steroidogenesis and cell differentiation (Figure 3) . Under the control of the RAAS, Ang II promotes aldosterone production through activation of PLC, calcium and protein kinase C signalling (reviewed in depth pre viously 134 ). By contrast, pro opiomelanocortin (POMC) derived ACTH, under regulation of the HPA axis, induces glucocorticoid synthesis by stimulating cAMP-protein kinase A (PKA) and MAPK signal transduction pathways (reviewed in depth previously 135 ). Mice deficient for both of the type1 Ang II receptors (Agtr1a -/-:Agtr1b -/-); the ACTH receptor (Mc2r); or Pomc exhibit normal adrenal histology at birth, [136] [137] [138] indicating that Ang II and ACTH are dispensable for normal fetal adrenal gland develop ment. However, these endocrine signals profoundly influ ence adrenocortical remodelling and maintenance of the adrenal cortex during adult life. The effects of activation of the RAAS and the HPA axis on adrenal gland architecture in mice are similar; initial differentiation and hyper trophy of steroidogenic cells occurs acutely, with subsequent chro nic stimulation resulting in increased cell proliferation through mechanisms that are not well established. 139 Rats consuming a lowsalt diet exhibited hypertrophic cells that had increased Cyp11b2 expression in the zona glomerulosa over the initial 3 days of the diet, which was followed by adrenal gland hyper plasia peaking 3-5 days after initia tion of diet. 140 The increase in the number of CYP11B2 + cells that occurred prior to proliferation is thought to be the direct result of differentiation of Shhexpressing cells into zona glomerulosa cells (see above), followed by proliferation to replace the population of progenitors. In accord with this notion, rats subsisting on a lowsalt diet for 3 days gained Cyp11b2expressing cells without induc tion of proliferation, which was concomitant with a ~50% reduction in Shh expression. 141 The bulk of replicating cells under chronic RAAS or ACTH stimulation initially reside within the undifferentiated zone before extending to the other zones. 140, 142 Conflicting data exist on whether ACTH is mitogenic in itself; 143 ACTH has been suggested to stimu late expression of growth factors, such as IGF2, rather than directly promoting cell proliferation. 144, 145 The integration of endocrine and local paracrine path ways toggles adrenocortical gene expression. Nr0b1, which encodes DAX1, is one of the genes regulated in this fashion. Nr0b1 is activated by local paracrine Wnt signalling in pre sumptive adrenocortical progenitors, which is thought to contribute to the maintenance of their undifferentiated state. 61, 75, 82 DAX1 inhibits SF1mediated steroido genesis (see above) 64 and DAX1 expression is also activated by excess glucocorticoid levels, leading to negative feedback regulation of steroid production. 146 By contrast, ACTH clears transcriptional coactivators from the proximal promoter of Nr0b1, presumably relieving DAX1mediated repression of SF1dependent steroidogenesis and enabling adrenocortical cell differentiation. 146 cAMP-PKA signalling pathway The cAMP-PKA pathway, the intracellular signal ling medi ator of the effects of various hormones, is cru cial for adrenal steroidogenesis and cell proliferation. Under nor mal conditions, activation of Gprotein coupled recep tors by hormones results in the activation of G pro teins with subsequent adenylate cyclase stimulation and generation of cAMP. cAMP binds to the regulatory sub units of PKA, which frees the catalytic subunits of PKA to phosphorylate downstream substrates that activate tr anscription of cAMPresponsive genes.
Genetic mutations of the cAMP-PKA pathway are asso ciated with an array of hyperproliferative adreno corti cal diseases in humans and in mouse models (Table 1) . Acti vating mutations in the GNAS gene, which encodes adenylate cyclasestimulating Gα protein (also known as G s protein), have been identified in patients with cortisol producing adrenal adenomas [147] [148] [149] and ACTHindependent macronodular adrenal hyper plasia (AIMAH), 150 and are the genetic basis of McCune-Albright syndrome. 151 Gainoffunction mutations in PRKACA, one of the three genes encoding the catalytic sub units of PKA, are the genetic basis of many cortisolpro ducing adrenal adenomas. 149, [152] [153] [154] Lossoffunction muta tions in PRKAR1A, which codes for one of the regulatory subunits of PKA, are responsible for primary pig mented nodular adrenal dysplasia 155 and Carney com plex. 155, 156 In different mouse models, genetic ablation or reduction of expres sion of Prkar1a variably recapitulates aspects of Carney complex. [157] [158] [159] [160] Adrenalspecific knockout of Prkar1a in mice results in autonomous adrenal hyperplasia and glucocorticoid production reminiscent of Cushing syn drome. 160 Additionally, Prkar1adeficient mouse adrenal glands exhibit reduced numbers of normal adult adrenal cells concomitant with centrifugal expansion of apoptosis insensitive fetal adrenallike cells, suggesting that normal adrenocortical cell differentiation and proliferation require proper regulation of PKA activity. 160 Interestingly, aber rant upregulation of PKA activity in the adrenal cortex has been associated with dysregulated Wnt signalling in both mice and humans. 147, 159 Finally, inactivating muta tions in PDE11A and PDE8B, which encode phospho diesterases that dampen cAMP signalling, have been associated with adrenal hyperplasia, 161 The studies detailed above highlight the involvement of paracrine and endocrine signalling in the establishment and maintenance of the adrenocortical stem and progeni tor cell niche. The Wnt pathway is critical for both devel opment and maintenance of the adrenocortical tissue, in part through activation of the Wnt target gene Nr0b1. 81, 82 DAX1 maintains the adrenocortical progenitor pool post natally, by acting as a negative regulator of SF1mediated steroidogenesis and cell differentiation. 64, 75 The adrenal (as opposed to gonadal) fate of adreno cortical progenitors is sustained by the TGFβ family member inhibinα. 117 The proliferative capacity of adreno cortical cells seems to be under the control of IGF2, FGFs, cAMP-PKA signal ling and SF1, 50, 56, 99, 104, 105, 121, 122 although the rules dictating which molecules regulate proliferation temporally and spatially remain to be elucidated. A key issue to under stand is how these different paracrine signals coordinate to maintain the adrenocortical stem and progenitor cell unit in terms of promoting proliferation and/or selfrenewal, quiescence, or terminal differen tiation. Differentiation of adrenocortical cells is in part under control of the hor mones Ang II and ACTH, which activate steroidogenesis in conjunction with cAMP-PKA signalling.
Future studies should aim to elucidate how the integra tion of paracrine and endocrine signals regulates prolif eration and differentiation of adrenocortical stem cells and progenitor cells in time and space. Although potential markers of adrenocortical stem cells and progenitor cells have been identified, the inability to isolate and culture these cells in vitro has been an impediment in this area of research. Given that the population of adrenocortical stem cells and progenitor cells is very small, methodolo gies that require ample starting material would necessitate expan sion of these cells in vitro following their isolation, yet proto cols for culturing adrenocortical stem and pro genitor cells are lacking. This challenge is likely to reflect the complexity of the integration of multiple signal ling pathways, an incomplete understanding of essential factors influencing the stem and progenitor cell niche and the inability to recapitulate the in vivo environment in a culture dish. Establishment of methods for the culturing of adrenocortical stem cells and progenitor cells will be critic al for future research efforts.
Diseases resulting in adrenal insufficiency (AHC, SERKAL, PHS and IMAGe) are consequences of lossof function mutations in the specific transcription factors (SF1, DAX1) and paracrine signalling pathways (Wnt, Hedgehog, IGF) that are critical for adrenocortical stem and progenitor cells. Conversely, activating mutations in these pathways result in adrenal tissue 'overgrowth' that contributes to the formation of adrenocortical hyper plasias, adenomas and carcinomas. These diseases might therefore reflect the consequences of adreno cortical stem and progenitor cell failure or overactivation. We present a comprehensive list of genetic mutations underlying a spectrum of adrenocortical diseases in Table 1 (primary dis orders of steroidogenesis due to lossoffunction muta tions in MC2R, MRAP and in genes encoding steroido genic enzymes that result in primary hypo plasias or compensatory hyperplasias [congenital adrenal hyper plasias and familial glucocorticoid deficiency] are not included but have been discussed extensively elsewhere 135 ). Although some of the genes listed in Table 1 have been shown to be important in the biology of adrenal disease, their involvement in normal adrenal gland development and homeostasis remains unclear. Conversely, a number of genes discussed in this Review have been shown to be involved in adrenocortical development and homeo stasis in mice, yet their role in human adrenal biology and disease remains unclear. Many genes that participate in stem and progenitor cell biology and contribute to disease states have been determined, but most likely many remain unknown. The powerful tool of next generation high throughput sequencing enables assessment of genetic perturbations on a genomic level. These experimental approaches will be likely to uncover new genes and path ways that are required for the maintenance of adreno cortical stem and progenitor cells and contribute to our understanding of the aetiology of adreno cortical diseases across the spectrum of adrenal failure to neoplasia.
Review criteria
PubMed and Google Scholar were used to find original full-length research articles and reviews published between 1866 and 2014. Search terms included "adrenocortical stem AND/OR progenitor", "adrenocortical shh", "adrenocortical wnt AND/OR betacatenin", "adrenocortical FGF", "adrenocortical IGF", "adrenocortical TGF-beta AND inhibin", "adrenocortical PKA", "adrenocortical hypoplasia", "adrenocortical development". The references contained within articles found through this search also served as a resource to identify additional pertinent articles for discussion.
